Peer-reviewedCC BY-NC-ND 4.0BMC Medicine
Comparative effectiveness of first-/second-generation EGFR-TKI combination therapy versus third-generation EGFR-TKI monotherapy in untreated locally advanced or metastatic EGFR-mutant NSCLC: a real-world, retrospective study in China
Related
- Cost-effectiveness of monotherapy and combination therapy for myopia control in Chinese children.
- Efficacy and Safety of Supramolecular Salicylic Acid Peeling Combined With Intense Pulsed Light Versus Intense Pulsed Light Monotherapy in Erythematotelangiectatic‐Predominant Rosacea: A Retrospective Real‐World Comparative Study
- PD-1-based combination therapy versus monotherapy in relapsed or refractory classical Hodgkin lymphoma: a single-center retrospective cohort study
- Comparative Effectiveness of Antidepressants and Second-Generation Antipsychotics for Agitation Among Nursing Home Residents with Dementia
- Comparative Effectiveness of Hysteroscopic Endometrial Resection Versus the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding: A Retrospective Cohort Study
BibTeX
@article{wu2026comparative,
title = {{Comparative effectiveness of first-/second-generation EGFR-TKI combination therapy versus third-generation EGFR-TKI monotherapy in untreated locally advanced or metastatic EGFR-mutant NSCLC: a real-world, retrospective study in China}},
author = {Xinwei Wu and Danni Wang and Yangbin Shi and Beibei Liu and Fangfei Qian and Ting Zhao and Jun Lu and Yanwei Zhang and Yuqing Lou and Baohui Han and Wei Zhang},
journal = {BMC Medicine},
year = {2026},
month = oct,
doi = {10.1186/s12916-026-05340-7},
url = {https://link.springer.com/article/10.1186/s12916-026-05340-7},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Comparative effectiveness of first-/second-generation EGFR-TKI combination therapy versus third-generation EGFR-TKI monotherapy in untreated locally advanced or metastatic EGFR-mutant NSCLC: a real-world, retrospective study in China
AU - Xinwei Wu
AU - Danni Wang
AU - Yangbin Shi
AU - Beibei Liu
AU - Fangfei Qian
AU - Ting Zhao
AU - Jun Lu
AU - Yanwei Zhang
AU - Yuqing Lou
AU - Baohui Han
AU - Wei Zhang
PY - 2026
DA - 2026/10/19
JO - BMC Medicine
DO - 10.1186/s12916-026-05340-7
UR - https://link.springer.com/article/10.1186/s12916-026-05340-7
SN - 1741-7015
ER -